| Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: long-term results of a multi-institutional … DR Gomez, C Tang, J Zhang, GR Blumenschein Jr, M Hernandez, JJ Lee, ... Journal of Clinical Oncology 37 (18), 1558-1565, 2019 | 1175 | 2019 |
| Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic … DR Gomez, GR Blumenschein, JJ Lee, M Hernandez, R Ye, DR Camidge, ... The lancet oncology 17 (12), 1672-1682, 2016 | 1104 | 2016 |
| Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial T Cascone, WN William Jr, A Weissferdt, CH Leung, HY Lin, A Pataer, ... Nature medicine 27 (3), 504-514, 2021 | 537 | 2021 |
| Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma S Goswami, T Walle, AE Cornish, S Basu, S Anandhan, I Fernandez, ... Nature medicine 26 (1), 39-46, 2020 | 310 | 2020 |
| Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified … JY Chang, RJ Mehran, L Feng, V Verma, Z Liao, JW Welsh, SH Lin, ... The Lancet Oncology 22 (10), 1448-1457, 2021 | 275 | 2021 |
| The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC) JR Brahmer, R Govindan, RA Anders, SJ Antonia, S Sagorsky, MJ Davies, ... Journal for immunotherapy of cancer 6, 1-15, 2018 | 263 | 2018 |
| Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens B Sepesi, TJ Watson, D Zhou, M Polomsky, VR Litle, CE Jones, ... Journal of the American College of Surgeons 210 (4), 418-427, 2010 | 218 | 2010 |
| Diets enriched in foods with high antioxidant activity reverse age-induced decreases in cerebellar β-adrenergic function and increases in proinflammatory cytokines C Gemma, MH Mesches, B Sepesi, K Choo, DB Holmes, PC Bickford Journal of Neuroscience 22 (14), 6114-6120, 2002 | 215 | 2002 |
| Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC): Clinical and correlative results from the NEOSTAR study. T Cascone, WN William, A Weissferdt, HY Lin, CH Leung, BW Carter, ... Journal of Clinical Oncology 37 (15_suppl), 8504-8504, 2019 | 213 | 2019 |
| Comprehensive T cell repertoire characterization of non-small cell lung cancer A Reuben, J Zhang, SH Chiou, RM Gittelman, J Li, WC Lee, J Fujimoto, ... Nature communications 11 (1), 603, 2020 | 206 | 2020 |
| TCR repertoire intratumor heterogeneity in localized lung adenocarcinomas: an association with predicted neoantigen heterogeneity and postsurgical recurrence A Reuben, R Gittelman, J Gao, J Zhang, EC Yusko, CJ Wu, R Emerson, ... Cancer discovery 7 (10), 1088-1097, 2017 | 198 | 2017 |
| Enhanced recovery decreases pulmonary and cardiac complications after thoracotomy for lung cancer RM Van Haren, RJ Mehran, GE Mena, AM Correa, MB Antonoff, ... The Annals of thoracic surgery 106 (1), 272-279, 2018 | 195 | 2018 |
| Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival—The University of Texas … M Blum Murphy, L Xiao, VR Patel, DM Maru, AM Correa, F G. Amlashi, ... Cancer 123 (21), 4106-4113, 2017 | 175 | 2017 |
| Preoperative and postoperative systemic therapy for operable non–small-cell lung cancer JE Chaft, Y Shyr, B Sepesi, PM Forde Journal of Clinical Oncology 40 (6), 546-555, 2022 | 169 | 2022 |
| Programmed death-ligand 1 heterogeneity and its impact on benefit from immune checkpoint inhibitors in NSCLC L Hong, MV Negrao, SS Dibaj, R Chen, A Reuben, JM Bohac, X Liu, ... Journal of Thoracic Oncology 15 (9), 1449-1459, 2020 | 166 | 2020 |
| Effect of neoadjuvant chemotherapy on the immune microenvironment in non–small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches ER Parra, P Villalobos, C Behrens, M Jiang, A Pataer, SG Swisher, ... Journal for immunotherapy of cancer 6, 1-11, 2018 | 155 | 2018 |
| Image analysis–based assessment of PD-L1 and tumor-associated immune cells density supports distinct intratumoral microenvironment groups in non–small cell lung carcinoma patients ER Parra, C Behrens, J Rodriguez-Canales, H Lin, B Mino, J Blando, ... Clinical Cancer Research 22 (24), 6278-6289, 2016 | 155 | 2016 |
| Development of an immune-pathology informed radiomics model for non-small cell lung cancer C Tang, B Hobbs, A Amer, X Li, C Behrens, JR Canales, EP Cuentas, ... Scientific reports 8 (1), 1922, 2018 | 146 | 2018 |
| Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial T Cascone, CH Leung, A Weissferdt, A Pataer, BW Carter, MCB Godoy, ... Nature medicine 29 (3), 593-604, 2023 | 144 | 2023 |
| Esophageal perforation: surgical, endoscopic and medical management strategies B Sepesi, DP Raymond, JH Peters Current opinion in gastroenterology 26 (4), 379-383, 2010 | 143 | 2010 |
